-
-
-
-
-
-
-
Jefferies Reiterates Buy Rating on Eli Lilly (LLY): 'early oral Wegovy launch is directionally encouraging'
-
-
-
-
-
-
-
Lilly weight-loss pill could be FDA-approved by year-end
-
-
-
-
-
-
-
Eli Lilly (LLY) PT Raised to $1,050 at Jefferies
-
-
-
-
-
-
-
Eli Lilly (LLY) PT Raised to $853 at Jefferies
-
-
-
-
-
-
-
Lilly to Divest BAQSIMI to Amphastar
-
-
-
-
-
-
-
Pre-Open Stock Movers 09/29: (GREE) (AUVI) (LCID) Higher; (LFMD) (LSPD) (EQT) Lower (more...)
-
-
-
-
-
-
-
Gilead's next step on coronavirus: inhaled remdesivir, other easier-to-use versions
-
73,260 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

